Evidence map›Paper›PMID 42905750›Full record

ArticlePLoS computational biology2026

SADRP: A structurally aware multi-modal framework for drug response prediction.

Ren Qi, Shujia Liu, Tianhong Quan, Tianru Wu, Alexey K Shaytan, Bin Liu

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ren QiSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.
Shujia LiuSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.
Tianhong QuanSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.
Tianru WuSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.
Alexey K ShaytanDepartment of Biology, Lomonosov Moscow State University, Moscow, Russia.
Bin LiuSchool of Computer Science and Technology, Beijing Institute of Technology, Beijing, China.ORCID https://orcid.org/0000-0002-8520-8374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationPredicting drug sensitivity across diverse cancer samples is a fundamental challenge in personalized therapy and drug discovery. This task requires comprehensive characterization of both drug and cancer cell line features. Current approaches often fail to fully capture the complex structural characteristics and interactions of drug compounds and struggle to integrate multi-omics features derived from the same sample, limiting their feature representation capacity. Consequently, there is a need for modeling frameworks that can jointly model molecular structural features and multi-modal cellular contexts in a unified manner.

resultsWe present SADRP, a structurally aware multi-modal framework for drug response prediction, designed to model complex molecular structures and multi-omics data. For drug representation, SADRP incorporates Shortest Distance Path (SDP) encoding and edge encoding to capture both topological relationships and bond-type chemical semantics. For cell line profiling, a multi-view interactive encoder integrates gene expression and DNA methylation, capturing cross-omics synergistic complementarity. SADRP consistently outperforms state-of-the-art methods, while also identifying potential therapeutic candidates and biomarkers, providing mechanistic insights and supporting applications in drug discovery and personalized medicine.

Indexed as

Antineoplastic AgentsComputational BiologyDrug DiscoveryNeoplasmsCell Line, TumorDNA MethylationHumansMultiomicsPrecision MedicineAntineoplastic Agents

Identifiers

PMID42905750
PMCPMC13686522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.